Kardium Inc. has developed an advanced system for the treatment of atrial fibrillation (AF), which affects more than 37 million people worldwide1 and can increase the risk of stroke by 500%.2
The Globe® Mapping and Ablation System is the most complete solution for AF, offering single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation — all in a single catheter. This allows electrophysiologists (EPs) to both ablate and confirm the effectiveness of the ablation in real-time.
The Globe Mapping and Ablation System records and displays tissue contact, temperature, and electrical activity in the atrium, allowing EPs to confirm tissue contact, ablate, and verify treatment success in real-time as they work inside the heart.
Now available in Europe.
Prof. Hans Kottkamp, Head of Electrophysiology,
Sana Hospital Benrath, Düsseldorf
AF is an electrical disorder of the upper chambers of the heart (the atria) that causes rapid electrical signals that may reach hundreds of beats per minute. These signals interfere with the ability of the upper chambers to contract in a coordinated way, causing decreased pumping action and passive blood flow in the heart.
Resetting heart rhythm
Catheter ablation is used to interrupt erratic electrical signals in targeted areas of heart tissue, interrupting arrhythmia and restoring the heart to a normal rhythm.
Targeting pulmonary veins
The four pulmonary veins that empty into the heart’s left atrium are most often where erratic signals originate. When successful, cardiac ablation prevents those signals from entering the heart, stopping the arrhythmia.
Creating lesions
Cardiac ablation works by intentionally scarring areas of heart tissue to either isolate or eliminate areas that are causing rapid and irregular heartbeats.
Treating non-invasively
A long, flexible tube, or catheter, is inserted through a blood vessel and moved into the heart to deploy the ablation system — which applies heat or extreme cold directly to the tissues isolated for treatment.
Other catheter ablation systems offer distinct yet limited functionality. Some use single-tip catheters with a single electrode to ablate anywhere in the atrium. Others use inflatable balloons to isolate pulmonary veins (PV) and freeze affected tissue. Both require multiple catheters to conduct mapping inside the atrium to identity AF sources and overall catheter ablation treatment efficacy remains low.
Kardium’s Globe® Mapping and Ablation System is the only system to combine rapid PV isolation, high-resolution mapping and atrial ablation into a complete solution. Based on more than a decade of research and development and more than 100 patents, the system includes a single spherical catheter with 122 electrodes, software for high-resolution mapping and ablation control, and a radio frequency (RF) generator for ablation.
Quick and easy pulmonary vein isolation (PVI)
The Globe System is used to interrupt erratic electrical signals around the pulmonary veins and restore the heart to a normal rhythm. Its sophisticated catheter with 122 electrodes enables rapid treatment and offers real-time insights to the EPs performing the procedure.
Continuous, high-definition mapping
The Globe System records and displays tissue contact, temperature, and electrical activity in the atrium, allowing EPs to confirm tissue contact, ablate, and verify treatment success in real-time as they work inside the heart.
Single catheter, complete solution
The Globe System combines best-in-class technologies into a single catheter, including the rapid and targeted ablation of balloon catheters, the flexibility of single-tip catheters, and the high-definition mapping of multi-electrode catheters. Complete functionality is available to the EP without the need to change catheters.
Proven in clinical trial
Successful trial completed with 60 patients in Europe.
Kardium was founded in 2007, creating a team of the best engineers, medical researchers, quality and compliance experts, and production staff to develop and manufacture the Globe Mapping and Ablation System. Guided by top medical advisors and leading clinical electrophysiologists, we are making a positive impact every day helping treat a condition that debilitates millions worldwide.
We’re always looking for new team members who can offer great skills, attitude, and work ethic. Kardium colleagues tend to stick with us for a long time, because they’re doing something that really matters.
At Kardium, our leadership team is committed to delivering maximum value, through our collective experience, our technology solutions, and an unwavering dedication to our vision of making the world a healthier place. Direct investment strengthens our ability to provide the most advanced, well-tested solutions of the highest-possible quality.
01/25/2021: Kardium announces $115M in new financing for innovative atrial fibrillation treatment
Fidelity Management & Research Company LLC and T. Rowe Price funds lead private financing round, which will accelerate commercial growth across Europe and enable a a clinical study for US Food and Drug Administration (FDA) approval.
11/11/2020: Kardium performs first cases with the Globe® Positioning System
Kardium performs first cases with the Globe® Positioning System
09/08/2020: Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System
Prof. Hans Kottkamp of Sana Hospital Benrath and Prof. Philipp Sommer of the Herz- und Diabeteszentrum NRW performed the first procedures with the Globe System.
Complete the following form and we will connect you to the most appropriate team member: